The clinical or strategic administration of compounds designed to stimulate the endogenous release of Growth Hormone (GH) from the anterior pituitary gland. Application refers to the measured introduction of these agents to enhance anabolic signaling, improve body composition, or support tissue repair. This is distinct from exogenous GH administration.
Origin
This terminology comes directly from pharmacology and endocrinology, specifically relating to agents that mimic or potentiate the action of Growth Hormone Releasing Hormone (GHRH) or Ghrelin. The focus is on leveraging the body’s natural secretory mechanisms.
Mechanism
Secretagogues function by interacting with specific receptors on somatotroph cells in the pituitary, often targeting GHS-R1a receptors or modulating the inhibitory input from somatostatin. This interaction triggers a cascade leading to the exocytosis of pre-formed GH vesicles into the systemic circulation. Effective application requires understanding the pulsatile nature of GH release to mimic natural physiology.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.